Dentsply Sirona expands partnership with Medline Sinclair to distribute its technology portfolio across Canada, enhancing access to digital dentistry solutions.
Quiver AI Summary
Dentsply Sirona has announced an expansion of its partnership with Medline Sinclair, Canada’s leading full-service dental distributor, effective September 1, 2026. This development will allow Medline Sinclair to distribute Dentsply Sirona's technology portfolio across Canada, enhancing access to digital dentistry solutions through its comprehensive network. The partnership builds on a successful history focused on dental consumables and is part of Dentsply Sirona’s strategy to strengthen its commercial presence in North America. Medline Sinclair, a key player in the Canadian healthcare market following its acquisition by Medline Canada, is poised to support dental practices as they modernize their operations with innovative solutions that improve productivity and profitability.
Potential Positives
- Expansion of partnership with Medline Sinclair increases access to Dentsply Sirona's technology portfolio across Canada.
- The collaboration strengthens Dentsply Sirona's commercial reach in North America, aligning with their strategic goals.
- Medline Sinclair's established presence and service capabilities enhance the distribution of Dentsply Sirona's innovative solutions to healthcare customers.
- This marks the sixth dealer network enhancement announced by Dentsply Sirona in 2026, demonstrating ongoing growth initiatives.
Potential Negatives
- The announcement of an expanded partnership with Medline Sinclair may indicate a reliance on third-party distributors for growth, which could raise concerns about Dentsply Sirona's direct control over product distribution and customer relationships.
- This press release, while outlining a positive partnership, does not mention any specific growth expectations or financial projections, potentially leading to investor concerns about the company’s future performance.
- Repeated mentions of dealer network enhancements in 2026 may suggest an ongoing struggle to strengthen their market presence, raising questions about the efficacy of their current market strategies.
FAQ
What is the new partnership announced by Dentsply Sirona?
Dentsply Sirona is expanding its partnership with Medline Sinclair to offer its technology portfolio across Canada starting September 1, 2026.
How does this expansion benefit Canadian dental practices?
The expansion increases access to Dentsply Sirona's digital dentistry solutions through Medline Sinclair's extensive sales and service network across Canada.
When was Medline Sinclair acquired by Medline Canada?
Medline Sinclair was acquired by Medline Canada Corporation in 2024, enhancing its position as a leading dental distributor in Canada.
What are Dentsply Sirona's main areas of focus?
Dentsply Sirona focuses on developing and marketing professional dental products and technologies to advance patient care and enhance dental practices.
Where is Dentsply Sirona headquartered?
Dentsply Sirona is headquartered in Charlotte, North Carolina, and operates globally in the dental product market.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$XRAY Insider Trading Activity
$XRAY insiders have traded $XRAY stock on the open market 9 times in the past 6 months. Of those trades, 9 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $XRAY stock by insiders over the last 6 months:
- GREGORY T LUCIER has made 3 purchases buying 65,000 shares for an estimated $894,054 and 0 sales.
- MICHAEL J BARBER purchased 15,175 shares for an estimated $150,004
- BRIAN P MCKEON purchased 10,000 shares for an estimated $101,199
- BRIAN T GLADDEN purchased 9,985 shares for an estimated $99,999
- BETSY D HOLDEN purchased 10,086 shares for an estimated $99,692
- CLYDE HOSEIN purchased 6,500 shares for an estimated $64,902
- JAMES D FORBES purchased 5,000 shares for an estimated $62,400
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$XRAY Revenue
$XRAY had revenues of $880M in Q1 2026. This is an increase of 0.11% from the same period in the prior year.
You can track XRAY financials on Quiver Quantitative's XRAY stock page.
You can access data on XRAY stock through the Quiver Quantitative API.
$XRAY Hedge Fund Activity
We have seen 185 institutional investors add shares of $XRAY stock to their portfolio, and 156 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SOUTHPOINT CAPITAL ADVISORS LP added 10,000,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $116,000,000
- ARMISTICE CAPITAL, LLC removed 4,298,000 shares (-58.9%) from their portfolio in Q1 2026, for an estimated $49,856,800
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 2,399,725 shares (-76.9%) from their portfolio in Q1 2026, for an estimated $27,836,810
- FREESTONE GROVE PARTNERS LP added 2,297,378 shares (+inf%) to their portfolio in Q1 2026, for an estimated $26,649,584
- MARSHALL WACE, LLP added 2,271,616 shares (+101.6%) to their portfolio in Q1 2026, for an estimated $26,350,745
- NEUBERGER BERMAN GROUP LLC added 1,900,712 shares (+inf%) to their portfolio in Q1 2026, for an estimated $22,048,259
- VOLORIDGE INVESTMENT MANAGEMENT, LLC removed 1,873,777 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $21,735,813
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$XRAY Analyst Ratings
Wall Street analysts have issued reports on $XRAY in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Underweight" rating on 06/04/2026
To track analyst ratings and price targets for $XRAY, check out Quiver Quantitative's $XRAY forecast page.
$XRAY Price Targets
Multiple analysts have issued price targets for $XRAY recently. We have seen 10 analysts offer price targets for $XRAY in the last 6 months, with a median target of $14.0.
Here are some recent targets:
- An analyst from BMO Capital set a target price of $12.0 on 07/09/2026
- Glen Santangelo from Barclays set a target price of $9.0 on 06/04/2026
- Kevin Caliendo from UBS set a target price of $17.0 on 05/07/2026
- Steven Valiquette from Mizuho set a target price of $14.0 on 05/06/2026
- Daniel Grosslight from Citigroup set a target price of $10.0 on 04/15/2026
- Michael Petusky from Barrington Research set a target price of $17.0 on 03/02/2026
- Jeffrey Johnson from Baird set a target price of $14.0 on 02/27/2026
Full Release
CHARLOTTE, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona, the world's largest diversified manufacturer of professional dental products and technologies, today announced an expansion of its long-standing relationship with Medline Sinclair, one of Canada's leading full-service dental distributors.
Effective September 1, 2026, Medline Sinclair will begin offering Dentsply Sirona's technology portfolio across Canada, building on a successful relationship that has historically focused on consumables. The expanded relationship increases access to Dentsply Sirona's digital dentistry solutions through Medline Sinclair's nationwide network of sales, service teams, and technical specialists.
Sinclair Dental was acquired by Medline Canada, Corporation in 2024 and as Medline Sinclair today, it is one of Canada’s largest manufacturers and distributors of healthcare and dental products and services from coast-to-coast. The company's strong reputation and broad geographic reach make it a valuable partner in delivering technology solutions to Canadian healthcare customers.
"Expanding access to our solutions through strong distribution partnerships is an important part of our North America strategy," said Mark Bezjak, Group Vice President, Americas RCO at Dentsply Sirona. "The expansion of our relationship with Medline Sinclair represents the sixth dealer network enhancement we have announced in 2026 and reflects our continued commitment to strengthening our commercial reach across North America. Medline Sinclair's established presence and service capabilities make them an ideal partner to expand access to our technology portfolio across Canada and support practices as they modernize their workflows."
“Bringing innovative solutions that enable our customers to be as productive and profitable as possible is a key driver when making a decision to add a new brand. Dentsply Sirona’s technology portfolio fits this strategy and we look forward to a mutually beneficial relationship.” said Peter Jugoon, SVP, Dental for Medline Sinclair.
About Dentsply Sirona
Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona’s innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit
www.dentsplysirona.com
for more information about Dentsply Sirona and its products.
Contact Information:
Dentsply Sirona Press Contact:
Marion Par-Weixlberger
Vice President, Corporate Communications, Public Relations & Brand
[email protected]
Dentsply Sirona Investors:
Wade Moody
Senior Manager, Investor Relations
[email protected]
